- Home
- ALT vs RRBI Comparison
ALT vs RRBI Comparison
Compare ALT & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | RRBI |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 484.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ALT | RRBI |
|---|---|---|
| Price | $3.61 | $71.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $16.33 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 4.8M | 35.0K |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | N/A | ★ 26.56 |
| EPS | N/A | ★ 6.01 |
| Revenue | $20,000.00 | ★ $119,363,000.00 |
| Revenue This Year | N/A | $8.05 |
| Revenue Next Year | N/A | $6.50 |
| P/E Ratio | ★ N/A | $11.88 |
| Revenue Growth | N/A | ★ 12.57 |
| 52 Week Low | $2.90 | $46.33 |
| 52 Week High | $7.83 | $78.01 |
Technical Indicators
Market Signals| Indicator | ALT | RRBI |
|---|---|---|
| Relative Strength Index (RSI) | 31.14 | 48.35 |
| Support Level | $3.83 | $73.00 |
| Resistance Level | $5.37 | $74.30 |
| Average True Range (ATR) | 0.32 | 1.79 |
| MACD | -0.18 | -0.50 |
| Stochastic Oscillator | 2.39 | 6.75 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.